Eli Lilly & Co.
LLY
NYSE
IPO1970
about LLY
Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells a wide range of human healthcare products, with a strong focus on therapeutic areas like diabetes, obesity, immunology, oncology, and neuroscience.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $980.13 | $1003.22 | $978.00 | $879.7B | 1.98M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$6.22 | n/a | n/a | 41.09% | 31.72% | 0% |
